vs
GE医疗（CCRN）与DLH Holdings Corp.（DLHC）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是DLH Holdings Corp.的3.4倍（$236.8M vs $68.9M）。DLH Holdings Corp.净利率更高（-1.9% vs -35.0%，领先33.1%）。GE医疗同比增速更快（-23.6% vs -24.1%）。GE医疗自由现金流更多（$16.1M vs $-4.8M）。过去两年DLH Holdings Corp.的营收复合增速更高（-17.4% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
DLH Holdings Corp.是一家总部位于美国的政府服务供应商，主要为退伍军人事务部、国防部、卫生与公众服务部等联邦机构提供技术赋能的医疗、物流、工程及任务支持服务，同时服务部分州及地方公共部门客户。
CCRN vs DLHC — 直观对比
营收规模更大
CCRN
是对方的3.4倍
$68.9M
营收增速更快
CCRN
高出0.5%
-24.1%
净利率更高
DLHC
高出33.1%
-35.0%
自由现金流更多
CCRN
多$20.9M
$-4.8M
两年增速更快
DLHC
近两年复合增速
-21.0%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $68.9M |
| 净利润 | $-82.9M | $-1.3M |
| 毛利率 | — | — |
| 营业利润率 | -30.2% | 2.1% |
| 净利率 | -35.0% | -1.9% |
| 营收同比 | -23.6% | -24.1% |
| 净利润同比 | -2109.7% | -218.7% |
| 每股收益（稀释后） | $-2.56 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNDLHC
| Q4 25 | $236.8M | $68.9M | ||
| Q3 25 | $250.1M | $81.2M | ||
| Q2 25 | $274.1M | $83.3M | ||
| Q1 25 | $293.4M | $89.2M | ||
| Q4 24 | $309.9M | $90.8M | ||
| Q3 24 | $315.1M | $96.4M | ||
| Q2 24 | $339.8M | $100.7M | ||
| Q1 24 | $379.2M | $101.0M |
净利润CCRNDLHC
| Q4 25 | $-82.9M | $-1.3M | ||
| Q3 25 | $-4.8M | $-920.0K | ||
| Q2 25 | $-6.7M | $289.0K | ||
| Q1 25 | $-490.0K | $878.0K | ||
| Q4 24 | $-3.8M | $1.1M | ||
| Q3 24 | $2.6M | $2.3M | ||
| Q2 24 | $-16.1M | $1.1M | ||
| Q1 24 | $2.7M | $1.8M |
毛利率CCRNDLHC
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 20.4% | — |
营业利润率CCRNDLHC
| Q4 25 | -30.2% | 2.1% | ||
| Q3 25 | -2.4% | 2.8% | ||
| Q2 25 | -2.1% | 4.5% | ||
| Q1 25 | -0.3% | 5.7% | ||
| Q4 24 | -1.1% | 6.2% | ||
| Q3 24 | 0.9% | 6.6% | ||
| Q2 24 | -5.7% | 5.7% | ||
| Q1 24 | 0.8% | 5.9% |
净利率CCRNDLHC
| Q4 25 | -35.0% | -1.9% | ||
| Q3 25 | -1.9% | -1.1% | ||
| Q2 25 | -2.4% | 0.3% | ||
| Q1 25 | -0.2% | 1.0% | ||
| Q4 24 | -1.2% | 1.2% | ||
| Q3 24 | 0.8% | 2.4% | ||
| Q2 24 | -4.7% | 1.1% | ||
| Q1 24 | 0.7% | 1.8% |
每股收益（稀释后）CCRNDLHC
| Q4 25 | $-2.56 | $-0.09 | ||
| Q3 25 | $-0.15 | $-0.07 | ||
| Q2 25 | $-0.20 | $0.02 | ||
| Q1 25 | $-0.02 | $0.06 | ||
| Q4 24 | $-0.13 | $0.08 | ||
| Q3 24 | $0.08 | $0.16 | ||
| Q2 24 | $-0.47 | $0.08 | ||
| Q1 24 | $0.08 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $257.0K |
| 总债务越低越好 | — | $133.5M |
| 股东权益账面价值 | $322.8M | $112.2M |
| 总资产 | $449.0M | $283.5M |
| 负债/权益比越低杠杆越低 | — | 1.19× |
8季度趋势，按日历期对齐
现金及短期投资CCRNDLHC
| Q4 25 | $108.7M | $257.0K | ||
| Q3 25 | $99.1M | $125.0K | ||
| Q2 25 | $81.2M | $194.0K | ||
| Q1 25 | $80.7M | $196.0K | ||
| Q4 24 | $81.6M | $451.0K | ||
| Q3 24 | $64.0M | $342.0K | ||
| Q2 24 | $69.6M | $423.0K | ||
| Q1 24 | $5.2M | $238.0K |
总债务CCRNDLHC
| Q4 25 | — | $133.5M | ||
| Q3 25 | — | $128.0M | ||
| Q2 25 | — | $138.3M | ||
| Q1 25 | — | $147.3M | ||
| Q4 24 | — | $162.2M | ||
| Q3 24 | — | $149.4M | ||
| Q2 24 | — | $160.9M | ||
| Q1 24 | — | $164.8M |
股东权益CCRNDLHC
| Q4 25 | $322.8M | $112.2M | ||
| Q3 25 | $408.1M | $113.0M | ||
| Q2 25 | $412.2M | $113.7M | ||
| Q1 25 | $418.2M | $112.8M | ||
| Q4 24 | $419.0M | $111.4M | ||
| Q3 24 | $424.7M | $110.1M | ||
| Q2 24 | $433.3M | $108.6M | ||
| Q1 24 | $462.4M | $106.8M |
总资产CCRNDLHC
| Q4 25 | $449.0M | $283.5M | ||
| Q3 25 | $538.2M | $290.7M | ||
| Q2 25 | $553.8M | $299.3M | ||
| Q1 25 | $576.2M | $306.6M | ||
| Q4 24 | $589.3M | $325.0M | ||
| Q3 24 | $597.4M | $314.4M | ||
| Q2 24 | $602.9M | $325.0M | ||
| Q1 24 | $648.4M | $325.9M |
负债/权益比CCRNDLHC
| Q4 25 | — | 1.19× | ||
| Q3 25 | — | 1.13× | ||
| Q2 25 | — | 1.22× | ||
| Q1 25 | — | 1.31× | ||
| Q4 24 | — | 1.46× | ||
| Q3 24 | — | 1.36× | ||
| Q2 24 | — | 1.48× | ||
| Q1 24 | — | 1.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $-4.8M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $-4.8M |
| 自由现金流率自由现金流/营收 | 6.8% | -7.0% |
| 资本支出强度资本支出/营收 | 0.9% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.1M | $29.2M |
8季度趋势，按日历期对齐
经营现金流CCRNDLHC
| Q4 25 | $18.2M | $-4.8M | ||
| Q3 25 | $20.1M | $10.7M | ||
| Q2 25 | $4.2M | $9.6M | ||
| Q1 25 | $5.7M | $14.5M | ||
| Q4 24 | $24.2M | $-11.5M | ||
| Q3 24 | $7.5M | $12.4M | ||
| Q2 24 | $82.4M | $4.6M | ||
| Q1 24 | $6.0M | $5.2M |
自由现金流CCRNDLHC
| Q4 25 | $16.1M | $-4.8M | ||
| Q3 25 | $17.9M | $10.7M | ||
| Q2 25 | $2.3M | $9.4M | ||
| Q1 25 | $3.8M | $14.0M | ||
| Q4 24 | $21.7M | $-12.1M | ||
| Q3 24 | $6.3M | $12.2M | ||
| Q2 24 | $79.6M | $4.5M | ||
| Q1 24 | $3.8M | $4.9M |
自由现金流率CCRNDLHC
| Q4 25 | 6.8% | -7.0% | ||
| Q3 25 | 7.2% | 13.1% | ||
| Q2 25 | 0.8% | 11.2% | ||
| Q1 25 | 1.3% | 15.6% | ||
| Q4 24 | 7.0% | -13.3% | ||
| Q3 24 | 2.0% | 12.7% | ||
| Q2 24 | 23.4% | 4.4% | ||
| Q1 24 | 1.0% | 4.9% |
资本支出强度CCRNDLHC
| Q4 25 | 0.9% | 0.1% | ||
| Q3 25 | 0.9% | 0.0% | ||
| Q2 25 | 0.7% | 0.3% | ||
| Q1 25 | 0.6% | 0.6% | ||
| Q4 24 | 0.8% | 0.6% | ||
| Q3 24 | 0.4% | 0.2% | ||
| Q2 24 | 0.8% | 0.2% | ||
| Q1 24 | 0.6% | 0.3% |
现金转化率CCRNDLHC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 33.12× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | -10.35× | ||
| Q3 24 | 2.92× | 5.42× | ||
| Q2 24 | — | 4.06× | ||
| Q1 24 | 2.23× | 2.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
DLHC
| Sales Channel Directly To Consumer | $64.5M | 94% |
| Sales Channel Through Intermediary | $4.4M | 6% |
